Eckert and Ziegler

EUZ.DE Small Cap

Healthcare · Medical Devices

Updated: Apr 5, 2026, 17:43 UTC

€14.57

-3.83% today

52W: €13.30 – €23.25

52W Low: €13.30 Position: 12.8% 52W High: €23.25

🔗 Compare Brokers

Key Metrics

P/E Ratio

18.68x

Price-to-Earnings

Forward P/E

16.22x

Forward Price/Earnings

P/S Ratio

2.99x

Price-to-Sales

EV/EBITDA

10.26x

Enterprise Value/EBITDA

Div. Yield

151%

Annual dividend yield

Market Cap

$911.7M

Market Capitalization

Revenue Growth

7.4%

YoY Revenue Growth

Profit Margin

13.06%

Net profit margin

ROE

17.07%

Return on Equity

Beta

1.68

Market sensitivity

Short Interest

—

% of float sold short

Avg. Volume

119,445

Average daily volume

Valuation Analysis

Signal

Fair

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Strong Buy

3 analysts

Avg. Price Target

€22.43

+53.97% upside

Target Range

€20.30 – €24.00

About the Company

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, hi

Sector: Healthcare Industry: Medical Devices Country: Germany Employees: 1,112 Exchange: GER